HomeAPTO • NASDAQ
add
Aptose Biosciences Inc
Previous close
$0.71
Day range
$0.70 - $0.76
Year range
$0.70 - $5.10
Market cap
13.31M USD
Avg Volume
63.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
1.02%
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.76M | -30.76% |
Net income | -9.64M | 29.51% |
Net profit margin | — | — |
Earnings per share | -1.00 | 66.84% |
EBITDA | -9.74M | 30.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.33M | -73.89% |
Total assets | 12.80M | -67.47% |
Total liabilities | 12.66M | -5.08% |
Total equity | 137.00K | — |
Shares outstanding | 16.31M | — |
Price to book | 71.01 | — |
Return on assets | -189.26% | — |
Return on capital | 5,879.52% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -9.64M | 29.51% |
Cash from operations | -11.76M | -4.08% |
Cash from investing | -1.99M | 32.74% |
Cash from financing | 11.85M | 23,594.00% |
Net change in cash | -1.91M | 86.59% |
Free cash flow | -8.17M | -29.16% |
About
Founded
1986
Headquarters
Website
Employees
36